Carolinas Hematology-Oncology is categorized under Clinics in Charlotte, NC .
Carolinas Hematology-Oncology was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Nicole Dwyer, Office Manager at the company’s branch by writing to 101 East West T Harris Boulevard # 1214, Charlotte, North Carolina NC 28262 or by phoning (704) 863-6160. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Carolinas Hematology-Oncology |
| Contact Person: | Nicole Dwyer, Office Manager |
| Address: | 101 East West T Harris Boulevard # 1214, Charlotte, North Carolina 28262 |
| Phone Number: | (704) 863-6160 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Clinics |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Carolinas Hematology-Oncology was started in 0 to provide professional Clinics under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Nicole Dwyer, Office Manager for inquiries that concern Carolinas Hematology-Oncology by calling the company number (704) 863-6160, as your correspondence is most welcome. Additionally, the physical location of the branch of Carolinas Hematology-Oncology can be found at the coordinates 35.305825,-80.749607 as well as the street address 101 East West T Harris Boulevard # 1214 in Charlotte, North Carolina 28262.
For its online presence, you may visit Carolinas Hematology-Oncology’s website at and engage with its social media outlets through on Twitter and on Facebook.